MHC-3 RT | Retatrutide (30mg)
(GLP-1/GIP/Glucagon Triple Receptor Agonist)
$259.99$229.99
MHC-3 RT | Retatrutide (30mg) is a next-generation triple receptor agonist that simultaneously targets the GLP-1, GIP, and Glucagon receptors, making it one of the most advanced peptide compounds currently under research. It represents a significant step forward in metabolic research, offering a multi-pathway approach to studying energy homeostasis, glucose metabolism, and lipid regulation.
Specifications:
Detail | Info |
|---|---|
Form | Lyophilized Powder |
Vial Sizes | 5mg, 10mg, 20mg, 30mg |
Vial Capacity | 3ml |
Storage | Cool, dry place away from direct light |
Purity | ≥99% |
Intended Use: This product is intended strictly for qualified laboratory researchers. It is not for human or veterinary consumption and must not be used as a drug, food additive, cosmetic, or household item.
Disclaimer: This compound is sold for in vitro research and educational purposes only. It has not been evaluated by the FDA and is not intended to diagnose, treat, cure, or prevent any disease. All buyers must be authorized research personnel or institutions.
Terms of Sale: By purchasing this product, you confirm that you are a qualified professional conducting lawful scientific research. Mile High Compounds and its affiliates are not liable for any misuse or mishandling of this material.